BARONI, GIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.434
NA - Nord America 1.200
AS - Asia 174
AF - Africa 3
Totale 2.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.196
PL - Polonia 904
SE - Svezia 121
IE - Irlanda 108
IT - Italia 108
HK - Hong Kong 59
RU - Federazione Russa 48
DE - Germania 47
CN - Cina 41
UA - Ucraina 39
SG - Singapore 28
FI - Finlandia 22
GB - Regno Unito 16
JO - Giordania 16
VN - Vietnam 16
CH - Svizzera 9
BE - Belgio 8
TR - Turchia 6
CA - Canada 4
KR - Corea 4
IN - India 3
EG - Egitto 2
ES - Italia 2
FR - Francia 2
JP - Giappone 1
SC - Seychelles 1
Totale 2.811
Salva come PNG Salva come JPEG
Città #
Warsaw 904
Fairfield 192
Dublin 108
Chandler 106
Ashburn 95
Woodbridge 88
Seattle 81
Cambridge 76
Houston 72
Jacksonville 67
Ann Arbor 63
Wilmington 52
Lawrence 36
Altamura 34
Hong Kong 34
Florence 33
Princeton 31
Singapore 22
Bremen 21
Beijing 18
Medford 18
Boston 17
San Diego 17
Dong Ket 16
Boardman 15
Buffalo 14
Shanghai 13
New York 10
Bern 9
Brussels 8
Norwalk 6
Izmir 5
Kent 4
Los Angeles 4
Phoenix 4
Rome 4
Seoul 4
Toronto 4
Verona 4
Falls Church 3
London 3
Moscow 3
Münster 3
Bani Suwayf 2
Barcelona 2
Castelfranco Di Sopra 2
Chennai 2
Hillsboro 2
Luton 2
Nanchang 2
Polistena 2
Salerno 2
San Giovanni Rotondo 2
Trumbull 2
Acton 1
Bologna 1
Covo 1
Genoa 1
Guangzhou 1
Hefei 1
Lappeenranta 1
Miami Beach 1
Milan 1
Mirano 1
New Bedfont 1
Perugia 1
Redmond 1
Tappahannock 1
Venezia 1
Washington 1
Zhuhai 1
Totale 2.360
Salva come PNG Salva come JPEG
Nome #
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 249
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 212
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 199
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 199
Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix. An investigation using CDX-2 and a limited immunohistochemical panel. 193
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 184
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 163
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer 123
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 108
CDX-2 homeobox gene expression. 100
Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. 90
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. 80
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. 77
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis. 77
Protease-activated receptor-2 downregulation is associated to vitiligo lesions 74
Epstein-Barr virus infection and p53 expression in HIV-related oral large B cell lymphoma 71
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors 60
Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. 58
Cervix adenocarcinoma and squamous cell carcinoma: 2 different morphologicentities? 56
Inducible nitric oxide synthase expression in human colorectal cancer - Correlation with tumor angiogenesis 53
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis 50
Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations 46
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 46
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy 45
Extra-mammary Paget's disease. An HPV-correlated neoplasia? 43
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. 42
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 42
HPV and p53 in urinary bladder carcinoma. 38
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 33
Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues 17
Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues 13
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 12
A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues 7
Totale 2.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020561 0 67 25 46 69 58 54 77 55 44 61 5
2020/2021455 37 45 22 59 18 40 24 40 41 77 19 33
2021/2022245 10 31 16 6 9 13 8 19 7 15 38 73
2022/2023549 45 106 42 39 49 93 67 18 63 4 11 12
2023/2024189 6 26 32 9 11 25 6 44 3 3 14 10
2024/202573 46 27 0 0 0 0 0 0 0 0 0 0
Totale 2.860